LRRK2 in Parkinson's disease and dementia with Lewy bodies

被引：0
|
作者：
Xiongwei Zhu
Asim Babar
Sandra L Siedlak
Qiwei Yang
Genta Ito
Takeshi Iwatsubo
Mark A Smith
George Perry
Shu G Chen
机构：
[1] Case Western Reserve University,Department of Pathology
[2] University of Tokyo,Department of Neuropathology and Neuroscience
[3] University of Texas at San Antonio,College of Sciences
来源：
Molecular Neurodegeneration | / 1卷
关键词：
Lewy Body; Dementia With Lewy Body; LRRK2 Mutation; Dementia With Lewy Body Case; LRRK2 Protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease
    Swirski, Marta
    Miners, Scott
    de Silva, Rohan
    Lashley, Tammaryn
    Ling, Helen
    Holton, Janice
    Revesz, Tamas
    Love, Seth
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6
  • [32] Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies
    Arima, K
    Hirai, S
    Sunohara, N
    Aoto, K
    Izumiyama, Y
    Uéda, K
    Ikeda, K
    Kawai, M
    BRAIN RESEARCH, 1999, 843 (1-2) : 53 - 61
  • [33] Update on dementia with Lewy bodies
    Burn D.J.
    Current Neurology and Neuroscience Reports, 2005, 5 (5) : 339 - 344
  • [34] Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease
    Morris, CM
    O'Brien, KK
    Gibson, AM
    Hardy, JA
    Singleton, AB
    NEUROSCIENCE LETTERS, 2003, 352 (02) : 151 - 153
  • [35] A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
    Monica H Breitve
    Luiza J Chwiszczuk
    Minna J Hynninen
    Arvid Rongve
    Kolbjørn Brønnick
    Carmen Janvin
    Dag Aarsland
    Alzheimer's Research & Therapy, 6
  • [36] Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease
    Tezuka, Toshiki
    Ishiguro, Mayu
    Taniguchi, Daisuke
    Osogaguchi, Ehoto
    Shiba-Fukushima, Kahori
    Ogata, Jun
    Ishii, Ryota
    Ikeda, Aya
    Li, Yuanzhe
    Yoshino, Hiroyo
    Matsui, Taro
    Kaida, Kenichi
    Funayama, Manabu
    Nishioka, Kenya
    Kumazawa, Fumihisa
    Matsubara, Tomoyasu
    Tsuda, Hitoshi
    Saito, Yuko
    Murayama, Shigeo
    Imai, Yuzuru
    Hattori, Nobutaka
    NEUROBIOLOGY OF DISEASE, 2024, 199
  • [37] Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant
    Cao, Ming
    Gu, Zhu-Qin
    Li, Yuan
    Zhang, Hui
    Dan, Xiao-Juan
    Cen, Shan-Shan
    Li, Da-Wei
    Chan, Piu
    NEUROSCIENCE BULLETIN, 2016, 32 (06) : 572 - 576
  • [38] LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model
    Zhao, Hien Tran
    John, Neena
    Delic, Vedad
    Ikeda-Lee, Karli
    Kim, Aneeza
    Weihofen, Andreas
    Swayze, Eric E.
    Kordasiewicz, Holly B.
    West, Andrew B.
    Volpicelli-Daley, Laura A.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 8 : 508 - 519
  • [39] Dementia with Lewy bodies: What is its relationship to Alzheimer's disease?
    Lippa, CF
    CONTEMPORARY NEUROPSYCHIATRY, 2001, : 190 - 194
  • [40] Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies
    Diaz-Galvan, Patricia
    Przybelski, Scott A.
    Algeciras-Schimnich, Alicia
    Figdore, Dan J.
    Lesnick, Timothy G.
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    Jack, Clifford R., Jr.
    Hmin, Paul
    Jain, Manoj K.
    Miyagawa, Toji
    Forsberg, Leah K.
    Fields, Julie A.
    Savica, Rodolfo
    Graff-Radford, Jonathan
    Ramanan, Vijay K.
    Jones, David T.
    Botha, Hugo
    St Louis, Erik K.
    Knopman, David S.
    Graff-Radford, Neill R.
    Ferman, Tanis J.
    Petersen, Ronald C.
    Lowe, Val J.
    Boeve, Bradley F.
    Kantarci, Kejal
    ALZHEIMERS & DEMENTIA, 2024, 20 (04) : 2485 - 2496
12345